iBio, Inc(NYSE MKT:IBIO) 
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scle...
Website: http://www.ibioinc.com
Founded: 2008
Full Time Employees: 43
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.72
H 3.80
L 3.06
C 3.23
V 787,389
10EMA 3.23
20EMA 3.23
60EMA 3.23
120EMA 3.23
250EMA 3.23